dpp 4 inhibitors and glp 1 agonists together GLP-1 receptor or DPP-4 inhibitors: How to guide the clinician? Prescribing pearls: A guide to
Description
Chou CC, et al

The next chapter involves an even more ambitious target: the glucagon receptor

Their idea was backed up by the findings of Unger and other researchers like Keith Buchanan, a Scottish specialist in metabolic medicine at Queens University in Belfast, Northern Ireland (Marks 2018

Then, we screened the titles and abstracts and removed the duplicate articles, reviews and conference abstracts, and 11 articles remained for evaluating the details of the full text to determine whether they met the inclusion criteria

First clinical data on a triagonist compound are available [28]

Supervision: Amjad Kanaan and Hilda E